Boromycin abrogates bleomycin-induced G2 checkpoint.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of antibiotics (Tokyo. 1968)

• Publication date

  2004-10-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.7164/ANTIBIOTICS.57.662PMID 15638327
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolic products of microorganisms

  2004cited by this paper
• The protein kinase C inhibitor Gö6976 is a potent inhibitor of DNA damage-induced S and G2 cell cycle checkpoints.

  2003cited by this paper
• Interference with PDK1-Akt survival signaling pathway by UCN-01 (7-hydroxystaurosporine)

  2002cited by this paper
• The effect of boromycin on the Ca2+ homeostasis

  2002cited by this paper
• Monensin‐mediated growth inhibition in human lymphoma cells through cell cycle arrest and apoptosis

  2002cited by this paper
• Inhibition of the G2 DNA Damage Checkpoint and of Protein Kinases Chk1 and Chk2 by the Marine Sponge Alkaloid Debromohymenialdisine*

  2001cited by this paper
• Radiosensitization of p53 mutant cells by PD0166285, a novel G(2) checkpoint abrogator.

  2001cited by this paper
• An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage.

  2000cited by this paper
• The G(2) DNA damage checkpoint targets both Wee1 and Cdc25.

  2000cited by this paper
• Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine.

  1999cited by this paper
• Sensitization of cancer cells to DNA damage-induced cell death by specific cell cycle G2 checkpoint abrogation.

  1999cited by this paper
• Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway

  1999cited by this paper
• A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase.

  1999cited by this paper
• Linkage of ATM to cell cycle regulation by the Chk2 protein kinase.

  1998cited by this paper
• Protein kinase mutants of human ATR increase sensitivity to UV and ionizing radiation and abrogate cell cycle checkpoint control.

  1998cited by this paper
• Overexpression of a kinase‐inactive ATR protein causes sensitivity to DNA‐damaging agents and defects in cell cycle checkpoints

  1998cited by this paper
• Unpredicted clinical pharmacology of UCN-01 caused by specific binding to human alpha1-acid glycoprotein.

  1998cited by this paper
• Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation

  1997cited by this paper
• p53, the Cellular Gatekeeper Review for Growth and Division

  1997cited by this paper
• Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25.

  1997cited by this paper
• Enhancement of cisplatin-induced cytotoxicity by 7-hydroxystaurosporine (UCN-01), a new G2-checkpoint inhibitor.

  1996cited by this paper
• Lactacystin increases LDL receptor level on HepG2 cells.

  1996cited by this paper
• Boromycin, an anti-HIV antibiotic.

  1996cited by this paper
• Selective radiosensitization of p53–deficient cells by caffeine–mediated activation of p34cdc2 kinase

  1996cited by this paper
• Apoptosis in 7-hydroxystaurosporine-treated T lymphoblasts correlates with activation of cyclin-dependent kinases 1 and 2.

  1995cited by this paper
• A single ataxia telangiectasia gene with a product similar to PI-3 kinase.

  1995cited by this paper
• Cell cycle control and cancer.

  1994cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• [The metabolic products of microorganisms. Boromycin].

  1967cited by this paper

• Genome-wide Screening of the Escherichia coli Keio Knockout Collection Identifies Genetic Determinants of Epetraborole Hypersusceptibility

  2025cites this paper
• Boromycin Has Potent Anti-Toxoplasma and Anti-Cryptosporidium Activity

  2021cites this paper
• A symbiotic bacterium of shipworms produces a compound with broad spectrum anti-apicomplexan activity

  2020cites this paper
• Achievements of Professor Satoshi Ōmura

  2017cites this paper
• Pharmaceutical applications of cyanobacteria—A review

  2015cites this paper
• Isolation and characterization of indigenous Streptomyces and Lentzea strains from soils containing boron compounds in Argentina

  2014cites this paper
• Habiterpenol, a novel abrogator of bleomycin-induced G2 arrest in Jurkat cells, produced by Phytohabitans suffuscus 3787_5

  2014cites this paper
• Sugar-borate esters--potential chemical agents in prostate cancer chemoprevention.

  2013cites this paper
• Streptomyces from Soils Contaminated with Boron Compounds

  2013cites this paper
• The effect of some boron derivatives on kanamycin resistance and survival of E. coli and P. aeruginosa in lake water.

  2012cites this paper
• Potentiation of bleomycin in Jurkat cells by fungal pycnidione.

  2012cites this paper
• Subcutenous xenografts of human T-lineage acute lymphoblastic leukemia Jurkat cells in nude mice.

  2011cites this paper
• Boron-containing compounds as preventive and chemotherapeutic agents for cancer.

  2010cites this paper
• Increased glutathione level is not involved in enhanced bleomycin sensitivity in cisplatin-resistant 2780CP cells.

  2008cites this paper
• Compounds that Abrogate the G2 Checkpoint

  2008cites this paper
• Biologically active compounds of semi-metals.

  2008cites this paper
• Empirical observations and mechanistic insights on the first boron-containing chiral selector for LC and supercritical fluid chromatography.

  2007cites this paper
• Fungal malformins inhibit bleomycin-induced G2 checkpoint in Jurkat cells.

  2007cites this paper
• Sespendole, a New Inhibitor of Lipid Droplet Synthesis in Macrophages, Produced by Pseudobotrytis terrestris FKA-25

  2006cites this paper